363 related articles for article (PubMed ID: 15509808)
1. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
2. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.
Dornan D; Shimizu H; Burch L; Smith AJ; Hupp TR
Mol Cell Biol; 2003 Dec; 23(23):8846-61. PubMed ID: 14612423
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.
Finlan L; Hupp TR
J Biol Chem; 2004 Nov; 279(47):49395-405. PubMed ID: 15337767
[TBL] [Abstract][Full Text] [Related]
4. MDMX inhibits the p300/CBP-mediated acetylation of p53.
Sabbatini P; McCormick F
DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
[TBL] [Abstract][Full Text] [Related]
5. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
6. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
8. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness.
Masumi A; Wang IM; Lefebvre B; Yang XJ; Nakatani Y; Ozato K
Mol Cell Biol; 1999 Mar; 19(3):1810-20. PubMed ID: 10022868
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.
Burýsek L; Yeow WS; Lubyová B; Kellum M; Schafer SL; Huang YQ; Pitha PM
J Virol; 1999 Sep; 73(9):7334-42. PubMed ID: 10438822
[TBL] [Abstract][Full Text] [Related]
10. DNA-dependent acetylation of p53 by the transcription coactivator p300.
Dornan D; Shimizu H; Perkins ND; Hupp TR
J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
[TBL] [Abstract][Full Text] [Related]
11. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment.
Masumi A; Ozato K
J Biol Chem; 2001 Jun; 276(24):20973-80. PubMed ID: 11304541
[TBL] [Abstract][Full Text] [Related]
12. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
13. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
14. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3.
Juang YT; Lowther W; Kellum M; Au WC; Lin R; Hiscott J; Pitha PM
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9837-42. PubMed ID: 9707562
[TBL] [Abstract][Full Text] [Related]
15. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
16. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
Zhu Q; Wani G; Wani MA; Wani AA
Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
[TBL] [Abstract][Full Text] [Related]
17. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.
Tanaka N; Ishihara M; Lamphier MS; Nozawa H; Matsuyama T; Mak TW; Aizawa S; Tokino T; Oren M; Taniguchi T
Nature; 1996 Aug; 382(6594):816-8. PubMed ID: 8752276
[TBL] [Abstract][Full Text] [Related]
18. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
[TBL] [Abstract][Full Text] [Related]
19. SSRP1 functions as a co-activator of the transcriptional activator p63.
Zeng SX; Dai MS; Keller DM; Lu H
EMBO J; 2002 Oct; 21(20):5487-97. PubMed ID: 12374749
[TBL] [Abstract][Full Text] [Related]
20. Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2.
Coccia EM; Del Russo N; Stellacci E; Orsatti R; Benedetti E; Marziali G; Hiscott J; Battistini A
Oncogene; 1999 Mar; 18(12):2129-37. PubMed ID: 10321737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
